Clarity Pharmaceuticals Ltd (CU6) — Financial Flexibility Index
Clarity Pharmaceuticals Ltd (CU6) has a Financial Flexibility Index of -2.08x as of December 2025. Free cash flow of AU$-47.54 Million (operating CF AU$-47.79 Million minus capex AU$257.84K) represents -2% of total liabilities (AU$22.86 Million). Check Clarity Pharmaceuticals Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Clarity Pharmaceuticals Ltd Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Clarity Pharmaceuticals Ltd across 8 annual periods. For the full cash flow conversion analysis, see Clarity Pharmaceuticals Ltd cash conversion from operations.
Annual Financial Flexibility Index for Clarity Pharmaceuticals Ltd (2018–2025)
Year-by-year free cash flow to debt coverage for Clarity Pharmaceuticals Ltd. Explore CU6 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.99x | AU$-54.59 Million | AU$-54.77 Million | AU$10.94 Million | ▲ +2.7% |
| 2024 | -5.13x | AU$-42.73 Million | AU$-43.24 Million | AU$8.33 Million | ▼ -44.2% |
| 2023 | -3.56x | AU$-27.45 Million | AU$-27.50 Million | AU$7.72 Million | ▼ -105.9% |
| 2022 | -1.73x | AU$-13.10 Million | AU$-13.31 Million | AU$7.59 Million | ▲ +47.0% |
| 2021 | -3.26x | AU$-7.62 Million | AU$-7.68 Million | AU$2.34 Million | ▲ +54.2% |
| 2020 | -7.13x | AU$-6.82 Million | AU$-6.83 Million | AU$956.09K | ▼ -119.5% |
| 2019 | -3.25x | AU$-3.69 Million | AU$-3.71 Million | AU$1.14 Million | ▼ -86.3% |
| 2018 | -1.74x | AU$-1.49 Million | AU$-1.50 Million | AU$857.04K | — |